View Item 

Show simple item record

Textilinin-1, an alternative anti-bleeding agent to aprotinin: Importance of plasmin inhibition in controlling blood loss
dc.contributor.authorFlight, Simone M.en_US
dc.contributor.authorJohnson, Lambro A.en_US
dc.contributor.authorDu, Qianyun S.en_US
dc.contributor.authorWarner, Roscoe L.en_US
dc.contributor.authorTrabi, Manuelaen_US
dc.contributor.authorGaffney, Patrick J.en_US
dc.contributor.authorLavin, Martin F.en_US
dc.contributor.authorde Jersey, Johnen_US
dc.contributor.authorMasci, Paul P.en_US
dc.date.accessioned2010-06-01T19:13:55Z
dc.date.available2010-06-01T19:13:55Z
dc.date.issued2009-04en_US
dc.identifier.citationFlight, Simone M.; Johnson, Lambro A.; Du, Qianyun S.; Warner, Roscoe L.; Trabi, Manuela; Gaffney, Patrick J.; Lavin, Martin F.; de Jersey, John; Masci, Paul P. (2009). "Textilinin-1, an alternative anti-bleeding agent to aprotinin: Importance of plasmin inhibition in controlling blood loss." British Journal of Haematology 145(2): 207-211. <http://hdl.handle.net/2027.42/72415>en_US
dc.identifier.issn0007-1048en_US
dc.identifier.issn1365-2141en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/72415
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=19236611&dopt=citationen_US
dc.format.extent222838 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights© 2009 Blackwell Publishing Ltden_US
dc.subject.otherTextilinin-1en_US
dc.subject.otherAprotininen_US
dc.subject.otherSerine Protease Inhibitoren_US
dc.subject.otherAnti-bleedingen_US
dc.subject.otherAnti-fibrinolyticen_US
dc.titleTextilinin-1, an alternative anti-bleeding agent to aprotinin: Importance of plasmin inhibition in controlling blood lossen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pathology, University of Michigan, Ann Arbor, Michigan, USAen_US
dc.contributor.affiliationotherSchool of Medicine, University of Queensland, Brisbane, Australiaen_US
dc.contributor.affiliationotherSchool of Chemical and Molecular Biosciences Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland, Australiaen_US
dc.contributor.affiliationotherQueensland Institute of Medical Research, Brisbane, Queensland Australiaen_US
dc.contributor.affiliationotherAcademic Department of Surgery, St Thomas’s Hospital, London, UKen_US
dc.contributor.affiliationotherUniversity of Queensland, Centre for Clinical Research, Brisbane, Queenslanden_US
dc.identifier.pmid19236611en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/72415/1/j.1365-2141.2009.07605.x.pdf
dc.identifier.doi10.1111/j.1365-2141.2009.07605.xen_US
dc.identifier.sourceBritish Journal of Haematologyen_US
dc.identifier.citedreferenceAusten, D.E.G. & Rhymes, I.L. ( 1975 ). A Laboratory Manual of Blood Coagulation. 1st edn. Blackwell Scientific Publications M, Oxford, UK.en_US
dc.identifier.citedreferenceBeierlein, W., Scheule, A.M., Dietrich, W. & Ziemer, G. ( 2005 ) Forty years of clinical aprotinin use: a review of 124 hypersensitivity reactions. Annals of Thoracic Surgery, 79, 741 – 748.en_US
dc.identifier.citedreferenceCohen, D.M., Norberto, J., Cartabuke, R. & Ryu, G. ( 1999 ) Severe anaphylactic reaction after primary exposure to aprotinin. Annals of Thoracic Surgery, 67, 837 – 838.en_US
dc.identifier.citedreferenceColman, R. ( 2006 ). Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 5th edn. Lippincott Williams & Wilkins, Philadelphia, PA.en_US
dc.identifier.citedreferenceEngles, L. ( 2005 ) Review and application of serine protease inhibition in coronary artery bypass graft surgery. American Journal of Health-System Pharmacy, 62, S9 – S14.en_US
dc.identifier.citedreferenceEspana, F., Medina, P., Navarro, S., Zorio, E., Estelles, A. & Anzar, J. ( 2005 ) The multifunctional protein C system. Current Medicinal Chemistry. Cardiovascular and Hematological Agents, 3, 119 – 131.en_US
dc.identifier.citedreferenceFergusson, D.A., Hebert, P.C., Mazer, D., Fremes, S., MacAdams, C., Murkin, J.M., Teoh, K., Duke, P.C., Arellano, R.A., Blajchman, M.A., Bussieres, J.S., Cote, D., Karski, J., Martineau, R., Robblee, J.A., Rodger, M., Wells, G., Clinch, J. & Pretorius, R. ( 2008 ) A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. New England Journal of Medicine, 358, 2319 – 2331.en_US
dc.identifier.citedreferenceFilippovich, I., Sorokina, N., Masci, P.P., de Jersey, J., Whitaker, A.N., Winzor, D.J., Gaffney, P.J. & Lavin, M.F. ( 2002 ) A family of textilinin genes, two of which encode proteins with antihaemorrhagic properties. British Journal of Haematology, 119, 376 – 384.en_US
dc.identifier.citedreferenceFlight, S., Johnson, L., Trabi, M., Gaffney, P., Lavin, M.F., de Jersey, J. & Masci, P. ( 2005 ) Comparison of textilinin-1 with aprotinin as serine protease inhibitors and as antifibrinolytic agents. Pathophysiology of Haemostasis and Thrombosis, 34, 188 – 193.en_US
dc.identifier.citedreferenceHekmat, K., Zimmermann, T., Kampe, S., Kasper, S.M., Weber, H.J., Geissler, H.J. & Mehlhorn, U. ( 2004 ) Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial. Current Medical Research and Opinion, 20, 121 – 126.en_US
dc.identifier.citedreferenceKarkouti, K. & Beattie, W.S. ( 2006 ) Aprotinin is useful as a hemostatic agent in cardiopulmonary surgery -No. Journal of Thrombosis and Haemostasis, 4, 1879 – 1881.en_US
dc.identifier.citedreferenceLevy, J.H., Tanaka, K.A. & Steiner, M.E. ( 2005 ) Evaluation and management of bleeding during cardiac surgery. Current Hematology Reports, 4, 368 – 372.en_US
dc.identifier.citedreferenceMangano, D.T., Tudor, I.C. & Dietzel, C. ( 2006 ) The risk associated with aprotinin in cardiac surgery. New England Journal of Medicine, 354, 353 – 365.en_US
dc.identifier.citedreferenceMasci, P.P., Whitaker, A.N., Sparrow, L.G., de Jersey, J., Winzor, D.J., Watters, D.J., Lavin, M.F. & Gaffney, P.J. ( 2000 ) Textilinins from Pseudonaja textilis textilis. Characterization of two plasmin inhibitors that reduce bleeding in an animal model. Blood Coagulation & Fibrinolysis, 11, 385 – 393.en_US
dc.identifier.citedreferenceMillers, E.K., Masci, P.P., Lavin, M.F., de Jersey, J. & Guddat, L.W. ( 2006 ) Crystallization and preliminary X-ray analysis of a Kunitz-type inhibitor, textilinin-1 from Pseudonaja textilis textilis. Acta Crystallographica Section F: Structural Biology and Crystallization Communications, 62, 642 – 645.en_US
dc.identifier.citedreferenceMorrison, J.F. & Walsh, C.T. ( 1988 ) The behaviour and significance of slow-binding enzyme inhibitors. Advances in Enzymology and Related Areas of Molecular Biology, 61, 201 – 301.en_US
dc.identifier.citedreferenceRoyston, D., Bidstrup, B.P., Taylor, K.M. & Sapsford, R.N. ( 1987 ) Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet, 8571, 1289 – 1291.en_US
dc.identifier.citedreferenceRoyston, D., Bidstrup, B.D., Taylor, K.M. & Sapsford, R.N. ( 1988 ) Aprotinin decreases the need for post-operative blood transfusions in patients having open heart surgery. Bibliotheca Cardiologica, 43, 73 – 82.en_US
dc.identifier.citedreferenceShaw, ST., Aoronson, D.E. & Mayer, D.L. ( 1972 ) Quantification of menstrual blood loss, further evaluation of the alkaline hematin method. Contraception, 5, 497 – 513.en_US
dc.identifier.citedreferenceSodha, NR., Boodhwani, M., Bianchi, C. & Sellke, F.W. ( 2006 ) Aprotinin in cardiac surgery. Expert Review of Cardiovascular Therapy, 4, 151 – 160.en_US
dc.identifier.citedreferenceSyrovets, T. & Simmet, T. ( 2004 ) Novel aspects and new roles for the serine protease plasmin. Cellular and Molecular Life Sciences, 61, 873 – 885.en_US
dc.identifier.citedreferenceTaby, O., Chabbat, J. & Steinbuch, M. ( 1990 ) Inhibition of activated protein C by aprotinin and the use of the insolubilized inhibitor for its purification. Thrombosis Research, 59, 27 – 35.en_US
dc.identifier.citedreferenceTanabe, K., Morishina, T., Shibutani, Y., Terada, Y., Hara, T., Shinohara, Y., Aoyagi, K., Kunitada, S. & Kondo, T. ( 1999 ) DX-9065a, an orally active factor Xa inhibitor, does not facilitate haemorrhage induced by tail transection or gastric ulcer at the effective doses in rat thrombosis model. Journal of Thrombosis and Haemostasis, 8, 828 – 836.en_US
dc.identifier.citedreferenceTanaka, K.A., Szlam, F., Katori, N., Vega, J.D. & Levy, J.H. ( 2004 ) Evaluation of a novel kallikrein inhibitor on hemostatic activation in vitro. Thrombosis Research, 113, 333 – 339.en_US
dc.identifier.citedreferenceWuthrich, B., Schmid, P., Schmid, E.R., Tornic, M. & Johansson, S.G.O. ( 1992 ) IgE-mediated anaphylactic reaction to aprotinin during anaesthesia. Lancet, 340, 173 – 174.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1365-2141.2009.07605.x.pdf
Size:
217.6KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.